Lenacapavir is available in both oral tablet form and as subcutaneous injections. It is available as oral tablets and ...

The Food and Drug Administration (FDA) has accepted the New Drug Application for doravirine/islatravir (DOR/ISL) for adults with virologically-suppressed HIV-1 infection.

Merck on Thursday said the application covers the investigational, once-daily, oral two-drug regimen for adults with HIV-1 infection that is virologically suppressed on antiretroviral therapy. The ...

News and Analysis Published: June 2009 Tapping into combination pills for HIV Bethan Hughes Nature Reviews Drug Discovery 8, 439–440 (2009) Cite this article ...